Hyderabad, India–based Zenara Pharma has launched a generic version of Pfizer’s (NYSE:PFE) COVID-19 antiviral Paxlovid (nirmatrelvir and ritonavir). Zenara Pharma is naming the generic version of the pill “Paxzen.” The antiviral is indicated for mild to moderate symptoms of COVID-19. India’s Central Drugs Standard Control Organisation (CDSCO) cleared the way for authorization of the drug…